12:26 18/07/2014 Notable Movers: New Residential Investment Corp (NRZ), TherapeuticsMD Inc ...
Notable Movers: New Residential Investment Corp (NRZ), TherapeuticsMD Inc ...
Techsonian (press release) - Jul 18, 2014
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) is a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology.

17:52 17/07/2014 Special News Alert: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Celldex ...
Special News Alert: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Celldex ...
Market News Call - Jul 17, 2014
Lakeway, NY - (MARKET NEWS CALL) - 7/17/2014— Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on ...
Hot News – Morgan Stanley (NYSE:MS), Twitter Inc (NYSE:TWTR), AEterna ... - Markets Insider
Aeterna Zentaris Now Covered by Analysts at HC Wainwright (AEZS) - Mideast Time

12:26 10/07/2014 Stocks to Track: AEterna Zentaris Inc. (USA) (AEZS), XOMA Corporation, (XOMA ...
Stocks to Track: AEterna Zentaris Inc. (USA) (AEZS), XOMA Corporation, (XOMA ...
Techsonian (press release) - Jul 10, 2014
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) closed at $1.25 in the last trading session with the overall traded volume of 940,879 million shares, versus the average volume of 734,304 shares.

21:15 07/07/2014 News Buzz - AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), DARA Biosciences ...
News Buzz - AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), DARA Biosciences ...
Techsonian (press release) - Jul 7, 2014
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) was trading lower by -2.98% to $1.27.So far, around 1.61 million shares have changed hands in this session.

13:57 07/07/2014 Unusual Volume at NASDAQ: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS ...
Unusual Volume at NASDAQ: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS ...
WallStreet Scope - Jul 7, 2014
Aeterna Zentaris Inc. (NASDAQ:AEZS) on 10 June announced the roll-out of a global resources optimization program as the Company pursues its strategy of transitioning into a commercially operating specialty biopharmaceutical company.

13:22 05/07/2014 Stocks to Track - AEterna Zentaris Inc. (USA) (AEZS), EDAP TMS S.A. (ADR ...
Stocks to Track - AEterna Zentaris Inc. (USA) (AEZS), EDAP TMS S.A. (ADR ...
Techsonian (press release) - Jul 5, 2014
Las Vegas, NV - July 05, 2014 - (TechSonian) - AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) is a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology.
Microcap Unusal Volume: AEterna Zentaris (NASDAQ:AEZS), AXT Inc (NASDAQ ... - Gaining Green

16:45 04/07/2014 Biotech Unusal Volume: StemCells Inc (NASDAQ:STEM), Synta ...
Biotech Unusal Volume: StemCells Inc (NASDAQ:STEM), Synta ...
Crazy Joys - Jul 4, 2014
On 10 JUNE AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced the roll-out of a global resources optimization program as the Company pursues its strategy of transitioning into a commercially operating specialty biopharmaceutical company.

14:30 04/07/2014 Worth Watching Stocks - Real Goods Solar, Inc. (NASDAQ:RGSE), AEterna ...
Worth Watching Stocks - Real Goods Solar, Inc. (NASDAQ:RGSE), AEterna ...
Techsonian (press release) - Jul 4, 2014
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), declared the roll-out of a global resources optimization program as the Company pursues its strategy of transitioning into a commercially operating specialty biopharmaceutical company.

11:52 03/07/2014 Microcap Gainers: Imation Corp. (NYSE:IMN), XG Technology Inc (NASDAQ ...
Microcap Gainers: Imation Corp. (NYSE:IMN), XG Technology Inc (NASDAQ ...
Crazy Joys - Jul 3, 2014
On June 10, Aeterna Zentaris Inc. (USA) (NASDAQ:AEZS)announced the roll-out of a global resources optimization program as the Company pursues its strategy of transitioning into a commercially operating specialty biopharmaceutical company.

13:00 02/07/2014 Worth Watching Stocks- Curis, Inc. (NASDAQ:CRIS), AEterna Zentaris Inc. (USA ...
Worth Watching Stocks- Curis, Inc. (NASDAQ:CRIS), AEterna Zentaris Inc. (USA ...
Techsonian (press release) - Jul 2, 2014
AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) declared that a poster will be presented on the design of its current ZoptEC (Zoptarelin doxorubicin in Endometrial Cancer) Phase 3 trial in women with advanced, recurrent or metastatic endometrial cancer.
Recent Study: AEterna Zentaris Inc. - Product Pipeline Review - 2014 - DigitalJournal.com
Gainers at Biotech: Alcobra (NASDAQ:ADHD), Aratana Therapeutics (NASDAQ ... - Tech News